Home | Medical Need | R&D Programmes | Company | Collaborations | News | Recent Press Releases   Northern Antibiotics presents new data on novel polymyxin compounds at the joint ICAAC/IDSA 2008 - October 28, 2008 Northern Antibiotics to present new data on key NAB compounds at the joint ICAAC/IDSA 2008 - September 8, 2008 Bad news to Bad bugs: Northern Antibiotics develops novel polymyxins with reduced toxicity - July 1, 2008 Publications and Posters   Ali, F.E., G. Cao, A. Poydal, T. Vaara, R. L. Nation, M. Vaara, and J. Li. 2009. Pharmacokinetics of novel antimicrobial cationic peptides NAB7061 and NAB739 in rats following intravenous administration. J. Antimicrob. Chemother. 64:1067-1070. Vaara, M., 2009. New approaches in peptide antibiotics. Curr. Opin. Pharmacol. 9:571-576. Vaara, M. et al, 2008. Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents. Click the link here. Vingsbo, C. et al., 2008. Novel Polymyxin Derivatives are Effective in Treating Peritoneal E.coli Infection in Mice. Ali, F. et al., 2008. Pharmacokinetics (PK) of Novel Anti-Gram-negative (G-) Antibiotics in Rat.
	Northern Antibiotics Ltd Mailing Address: P.O.Box 30, FIN-00721, Helsinki, Finland Visiting Address: Eskolantie 1, FIN-00720, Helsinki, Finland Phone: + 358-50-355 0822 Fax: +358-9-6842 0130 E-mail: info@northernantibiotics.com
	Copyright © 2007 Northern Antibiotics Ltd